Medtronic (MDT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Nasdaq futures fall after Samsung's record profit fails to allay chip jitters
- Oil gains after vessel attacks near Strait of Hormuz
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Medtronic reports second quarter fiscal 2025 financial results
November 19, 2024 6:45 AM ESTDelivering on commitments, executing ahead of expectations, and raising guidance
Innovation driving sustained growth across many franchises:Â TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation
GALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ --Â Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25,... More
